Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures.

In this paper we adapt an avascular tumour growth model to compare the effects of drug application on multicell spheroids and on monolayer cultures. The model for the tumour is based on nutrient driven growth of a continuum of live cells, whose birth and death generates volume changes described by a velocity field. The drug is modelled as an externally applied, diffusible material capable of killing cells, both linear and Michaelis-Menten kinetics for drug action on cells being studied. Numerical solutions of the resulting system of partial differential equations for the multicell spheroid case are compared with closed form solutions of the monolayer case, particularly with respect to the effects on the cell kill of the drug dosage and of the duration of its application. The results show an enhanced survival rate in multicell spheroids compared to monolayer cultures, consistent with experimental observations, and indicate that the key factor determining this is drug penetration. An analysis of the large time tumour spheroid response to a continuously applied drug at fixed concentration reveals up to three stable large time solutions, namely the trivial solution (i.e. a dead tumour), a travelling wave (continuously growing tumour) and a sublinear growth case in which cells reach a pseudo-steady-state in the core. Each of these possibilities is formulated and studied, with the bifurcations between them being discussed. Numerical solutions reveal that the pseudo-steady-state solutions persist to a significantly higher drug dose than travelling wave solutions.

[1]  P. Hunter,et al.  An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours. , 1997, British Journal of Cancer.

[2]  P. A. Wilson,et al.  In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids. , 1982, British Journal of Cancer.

[3]  Z. Agur,et al.  A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs. , 1992, Mathematical biosciences.

[4]  T. Kwok,et al.  The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs — An in vitro study using EMT6 multicellular spheroids , 1985, International journal of cancer.

[5]  J. L. Boldrini,et al.  Chemotherapeutic treatments: a study of the interplay among drug resistance, toxicity and recuperation from side effects. , 1997, Bulletin of mathematical biology.

[6]  T. Nederman Effects of vinblastine and 5-fluorouracil on human glioma and thyroid cancer cell monolayers and spheroids. , 1984, Cancer Research.

[7]  I. Tannock,et al.  Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines. , 1990, Journal of the National Cancer Institute.

[8]  J. King,et al.  Mathematical modelling of avascular-tumour growth. , 1997, IMA journal of mathematics applied in medicine and biology.

[9]  J. King,et al.  Mathematical modelling of avascular-tumour growth. II: Modelling growth saturation. , 1999, IMA journal of mathematics applied in medicine and biology.

[10]  H. H. Evans,et al.  Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: influence of growth kinetics, growth environment and DNA packaging. , 1993, British journal of cancer.

[11]  J. Murray,et al.  A mathematical model of glioma growth: the effect of chemotherapy on spatio‐temporal growth , 1995, Cell proliferation.

[12]  R. Durand Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro. , 1981, Cancer research.

[13]  A. Oloumi,et al.  Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors. , 2000, Cancer research.

[14]  W. Düchting,et al.  Modeling and simulation of growing spheroids. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[15]  H M Byrne,et al.  A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy. , 2000, Mathematical biosciences.

[16]  T. Kwok,et al.  The response to cytotoxic drugs of EMT6 cells treated either as intact or disaggregated spheroids. , 1985, British Journal of Cancer.

[17]  S. Cole,et al.  Uptake kinetics of monoclonal antibodies by human malignant melanoma multicell spheroids. , 1988, Cancer research.

[18]  D. Kerr,et al.  Cytotoxic drug penetration studies in multicellular tumour spheroids. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[19]  C. Erlichman,et al.  Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice. , 1984, Cancer research.

[20]  J. Folkman,et al.  SELF-REGULATION OF GROWTH IN THREE DIMENSIONS , 1973, The Journal of experimental medicine.

[21]  John A. Adam,et al.  A mathematical model of cycle-specific chemotherapy , 1995 .

[22]  J. Masters,et al.  Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy. , 1989, Cancer research.

[23]  Herbert D. Landahl,et al.  Heuristic modeling of drug delivery to malignant brain tumors , 1980, Journal of Pharmacokinetics and Biopharmaceutics.

[24]  R. Murphy,et al.  Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids. , 1999, Biotechnology and bioengineering.

[25]  S. Fox,et al.  TUMOUR ANGIOGENESIS , 1996, The Journal of pathology.

[26]  W. Mueller‐Klieser,et al.  Multicellular spheroids , 2004, Journal of Cancer Research and Clinical Oncology.

[27]  D. Deen,et al.  Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea. , 1984, Cancer research.

[28]  E. Wibe Resistance to vincristine of human cells grown as multicellular spheroids. , 1980, British Journal of Cancer.